Floatz logo

IMMUNOGLOBULIN G4, ANTI-(HUMAN ANTIGEN RECEPTOR KIR (KILLER CELL IMMUNOGLOBULIN-LIKE)) (HUMAN MONOCLONAL ANTI-KIR(1-7F9) HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ANTI-KIR(1-7F9) LIGHT CHAIN, DIMER

First or Second Relapse

Innate Pharmamonoclonal_antibodyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the First or Second Relapse cohort.

Asset / SponsorPhaseRating
cc-5013
Innate Pharma
Phase 1CC

Same molecule, other indications

IMMUNOGLOBULIN G4, ANTI-(HUMAN ANTIGEN RECEPTOR KIR (KILLER CELL IMMUNOGLOBULIN-LIKE)) (HUMAN MONOCLONAL ANTI-KIR(1-7F9) HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ANTI-KIR(1-7F9) LIGHT CHAIN, DIMER is also rated in:

smoldering plasma cell myelomaDormant
B
Indicative ·
57 / 100
View asset →
plasma cell myelomaDormant
CCC
Indicative ·
53 / 100
View asset →
acute myeloid leukemiaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →